Sangamo Therapeutics Inc (SGMO)
0.493
-0.03
(-5.36%)
USD |
NASDAQ |
Apr 24, 16:00
0.4939
0.00 (0.00%)
After-Hours: 20:00
Sangamo Therapeutics Cash from Investing (TTM): 153.53M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 153.53M |
| September 30, 2023 | 158.44M |
| June 30, 2023 | 107.35M |
| March 31, 2023 | 93.31M |
| December 31, 2022 | 59.28M |
| September 30, 2022 | 69.31M |
| June 30, 2022 | 143.74M |
| March 31, 2022 | 204.62M |
| December 31, 2021 | 248.20M |
| September 30, 2021 | 65.11M |
| June 30, 2021 | -238.37M |
| March 31, 2021 | -250.06M |
| December 31, 2020 | -271.63M |
| September 30, 2020 | -157.57M |
| June 30, 2020 | 68.71M |
| March 31, 2020 | -21.28M |
| December 31, 2019 | -59.80M |
| September 30, 2019 | 19.44M |
| June 30, 2019 | 118.42M |
| March 31, 2019 | -181.34M |
| December 31, 2018 | -178.11M |
| September 30, 2018 | -212.97M |
| June 30, 2018 | -322.80M |
| March 31, 2018 | -95.03M |
| December 31, 2017 | -77.40M |
| Date | Value |
|---|---|
| September 30, 2017 | -99.11M |
| June 30, 2017 | -40.03M |
| March 31, 2017 | 40.48M |
| December 31, 2016 | 18.12M |
| September 30, 2016 | 57.10M |
| June 30, 2016 | 47.04M |
| March 31, 2016 | 42.72M |
| December 31, 2015 | 77.46M |
| September 30, 2015 | 31.90M |
| June 30, 2015 | -73.54M |
| March 31, 2015 | -86.10M |
| December 31, 2014 | -100.66M |
| September 30, 2014 | -169.28M |
| June 30, 2014 | -84.53M |
| March 31, 2014 | -60.50M |
| December 31, 2013 | -68.12M |
| September 30, 2013 | 7.925M |
| June 30, 2013 | 6.514M |
| March 31, 2013 | 2.839M |
| December 31, 2012 | 11.32M |
| September 30, 2012 | -0.893M |
| June 30, 2012 | 18.88M |
| March 31, 2012 | -22.46M |
| December 31, 2011 | -20.00M |
| September 30, 2011 | -11.10M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-271.63M
Minimum
Dec 2020
248.20M
Maximum
Dec 2021
26.88M
Average
68.71M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
| AIM ImmunoTech Inc | -0.832M |
| Perspective Therapeutics Inc | 24.37M |
| Protalix BioTherapeutics Inc | -16.71M |
| Electromed Inc | -1.219M |
| Armata Pharmaceuticals Inc | -8.134M |